Canada Veterinary Ocular Medicine Market Size, by Indication (2024–2032)

The distribution of ocular conditions in Canadian veterinary practice in 2024 was characterized by a significant focus on conjunctivitis, which recorded a market value of USD 9,164.44 thousand, followed by corneal complications at USD 7,470.22 thousand. Among all indications, conjunctivitis dominated the Canada Veterinary Ocular Market in 2024, representing the highest demand, while conditions such as cataract and glaucoma recorded comparatively lower values, reflecting limited clinical focus. The substantial share of conjunctivitis was attributed to its high prevalence in companion animals and the need for timely therapeutic interventions, driving consistent veterinary attention and investment in effective treatment options.

In 2025, conjunctivitis is estimated to continue leading the Canada Veterinary Ocular Market with USD 9,395.76 thousand, while corneal complications remain the second-highest segment. Looking ahead to 2032, conjunctivitis is projected to reach USD 12,476.05 thousand, maintaining its dominant position, whereas corneal complications are projected to grow steadily to USD 10,531.10 thousand. The comparatively lower growth of other indications is expected to highlight their niche clinical demand. This sustained market leadership of conjunctivitis and corneal complications is primarily driven by increasing awareness among pet owners, the rising prevalence of ocular disorders, and the adoption of specialized veterinary therapeutics across Canada.